Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
TOP SEARCHES: OCT // Canaloplasty // AMD
In this issue
Ranibizumab study
Pre-treating Corneas
Controversy
Optical Implant Award
European availability
More Controversies
Survey

Are you planning to visit the World Ophthalmology Congress in Berlin?

Yes  
No  
Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Pamela Brook, editor.

Click here to contact Neil Hanley, sales manager.

May 6, 2010


Ranibizumab injections in combination with laser therapy offers new treatment for DME
The Diabetic Retinopathy Clinical Research Network study, published online in Ophthalmology has shown that ranibizumab injections, in combination with laser treatment has produced better vision results than in patients treated by laser alone for diabetic macular oedema More...
The Benefits of Pre-Treating Corneas
An approach to pre-treating two corneal conditions that makes for better refractive surgery by Asim Piracha, MD, Louisville, Kentucky, has been published in the Review of Ophthalmology. More...
Avastin/Lucentis controversy continues
“Why was Lucentis, at $2000 per dose chosen for the study, rather than Avastin at $50 per dose?” so asks Irv Arons in his blogspot. More...

Heidelberg Engineering complements the gold standard of structural glaucoma diagnosis, the Heidelberg Retina Tomograph (HRT) with an innovative and reliable partner, the Heidelberg Edge Perimeter (HEP). Read more...

Orbital implant receives innovation award
The new AlphaSphere Orbital Implant ophthalmic device has been awarded the 2010 Alpha Award for Innovation In Engineering & Technology presented by the Engineering Society of Detroit. More...
Retmarker now available in Europe
Critical Health has announced that Retmarker, its software solution for decision support in the ophthalmology domain, attained the right to hold the CE 0197 branding, that classifies it as a Class IIa Medical Device at a European level. More...

More controversies...
The World Congress on Controversies In Ophthalmology (COPHy) will take place in Barcelona, Spain, from 3–6 March 2011, following the first event held in the Czech Republic in March this year. More...

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.